Joseph Sobota, M D | |
2339 Pennsylvania Ave., Harbor Springs, MI 49740-4253 | |
(269) 567-0240 | |
Not Available |
Full Name | Joseph Sobota |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 2339 Pennsylvania Ave., Harbor Springs, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982062154 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 4301028352 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joseph Sobota, M D Po Box 4253, Harbor Springs, MI 49740-4253 Ph: (269) 567-0240 | Joseph Sobota, M D 2339 Pennsylvania Ave., Harbor Springs, MI 49740-4253 Ph: (269) 567-0240 |
News Archive
A common genetic variation, ApoE4, linked to Alzheimer's disease greatly raises the likelihood of tiny brain bleeds in some men, scientists have found.
The Michael J. Fox Foundation for Parkinson's Research is teaming up with EHE International to raise awareness of the fight against Parkinson's disease. For the month of July, EHE International has kindly donated a 115-square-foot window space at 10 Rockefeller Plaza to showcase the many ways ordinary citizens can support the Foundation through its grassroots fundraising arm, Team Fox.
A microscopic corn-and-shrimp cocktail could eventually make DNA-based vaccinations and cancer-treating gene therapies an easier pill to swallow, according to new research from the University of Nebraska-Lincoln.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.
House dust mite allergy is a surprisingly prevalent problem. Something like 27% of the U.S. population and 20% of the European population are what's called skin-prick test positive for house dust mites, which is a test for sensitivity to allergens to find out if a person is likely to get that allergy.
› Verified 8 days ago